For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 ...
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk ...
Verywell Health on MSN
What You Need to Know About Micrometastases
Medically reviewed by Marla Anderson, MD Key Takeaways Micrometastases are tiny cancer cell clusters too small to be seen on ...
A gene expression profile-based test can spot melanoma patients who have a low risk of cancer spreading to their lymph nodes.
MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph ...
From blood tests that predict recurrence to smarter, less invasive treatments, 2025 is delivering real hope—especially for ...
MOHAMED AL BATTASHIMUSCAT, NOV 4The World Cancer Congress, organised by the Oman Cancer Association (OCA) in collaboration with the Ministry ...
A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma ...
Early detection, advanced drug therapies, and less invasive surgeries are transforming breast cancer care, offering better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback